Sir Run Run Shaw Hospital

Hangzhou 310018

2 studies enrolling now · 9 studies all time

What they study most

Alzheimer Disease, Carcinoma, Hepatocellular, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Gastric Cancer, Generalized Myasthenia Gravis, Neoplasm Metastasis, Ulcerative Colitis, Urinary Bladder Neoplasms, Ventricular Tachycardia (VT)

Studies at this site

• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis — Stopped early
• A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer — Completed
• Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) — Stopped early
• A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma — Completed
• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. — Completed
• Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial — Completed